The logo of British drugmaker GlaxoSmithKline is shown on a building in Shanghai, November 11, 2019. /CFP The U.S. Food and Drug Administration on Thursday approved a long-acting HIV injection
The logo of British drugmaker GlaxoSmithKline is shown on a building in Shanghai, November 11, 2019. /CFP The U.S. Food and Drug Administration on Thursday approved a long-acting HIV injection
简体中文
